Last updated on February 2019

A Study of Tofacitinib in Patients With Ulcerative Colitis in Stable Remission


Brief description of study

This study is a follow up study for subjects with Ulcerative Colitis (UC) in stable remission designed to evaluate flexible dosing of CP-690,550.

Clinical Study Identifier: NCT03281304

Contact Investigators or Research Sites near you

Start Over

Pfizer CT.gov Call Center

Osaka City University Hospital
Osaka, Japan
9.56miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.